Moderna, Inc.
做多

MRNA after the published data

91
MRNA announced Phase 3 trial results late last night emphasizing the need for a booster shot. On Friday the FDA meets to discuss this issue. Lots of free room on the chart if the decision is positive.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。